T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis.
D000328:Adult; D000368:Aged; D016516:CD4-CD8 Ratio; D005260:Female; D006526:Hepatitis C / Q000276:immunology / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000276:immunology / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011994:Recombinant Proteins; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins